316 related articles for article (PubMed ID: 24632748)
1. Efficacy of combination therapy with oseltamivir phosphate and azithromycin for influenza: a multicenter, open-label, randomized study.
Kakeya H; Seki M; Izumikawa K; Kosai K; Morinaga Y; Kurihara S; Nakamura S; Imamura Y; Miyazaki T; Tsukamoto M; Yanagihara K; Tashiro T; Kohno S
PLoS One; 2014; 9(3):e91293. PubMed ID: 24632748
[TBL] [Abstract][Full Text] [Related]
2. Assessment of efficacy of Oseltamivir-Azithromycin combination therapy in prevention of Influenza-A (H1N1)pdm09 infection complications and rapidity of symptoms relief.
Ishaqui AA; Khan AH; Sulaiman SAS; Alsultan MT; Khan I; Naqvi AA
Expert Rev Respir Med; 2020 May; 14(5):533-541. PubMed ID: 32053044
[No Abstract] [Full Text] [Related]
3. Efficacy of Clarithromycin-Naproxen-Oseltamivir Combination in the Treatment of Patients Hospitalized for Influenza A(H3N2) Infection: An Open-label Randomized, Controlled, Phase IIb/III Trial.
Hung IFN; To KKW; Chan JFW; Cheng VCC; Liu KSH; Tam A; Chan TC; Zhang AJ; Li P; Wong TL; Zhang R; Cheung MKS; Leung W; Lau JYN; Fok M; Chen H; Chan KH; Yuen KY
Chest; 2017 May; 151(5):1069-1080. PubMed ID: 27884765
[TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory effects of adjunctive macrolide treatment in adults hospitalized with influenza: A randomized controlled trial.
Lee N; Wong CK; Chan MCW; Yeung ESL; Tam WWS; Tsang OTY; Choi KW; Chan PKS; Kwok A; Lui GCY; Leung WS; Yung IMH; Wong RYK; Cheung CSK; Hui DSC
Antiviral Res; 2017 Aug; 144():48-56. PubMed ID: 28535933
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of oseltamivir-zanamivir combination compared to each monotherapy for seasonal influenza: a randomized placebo-controlled trial.
Duval X; van der Werf S; Blanchon T; Mosnier A; Bouscambert-Duchamp M; Tibi A; Enouf V; Charlois-Ou C; Vincent C; Andreoletti L; Tubach F; Lina B; Mentré F; Leport C;
PLoS Med; 2010 Nov; 7(11):e1000362. PubMed ID: 21072246
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of Ergoferon versus oseltamivir in adult outpatients with seasonal influenza virus infection: a multicenter, open-label, randomized trial.
Rafalsky V; Averyanov A; Bart B; Minina E; Putilovskiy M; Andrianova E; Epstein O
Int J Infect Dis; 2016 Oct; 51():47-55. PubMed ID: 27616034
[TBL] [Abstract][Full Text] [Related]
7. [Ergoferon and oseltamivir in treatment of influenza: results of multicentre randomized comparative clinical trial].
Aver'ianov AV; Babkin AP; Bart BIa; Volchetskiĭ AL; Minina ES; Kozyrev OA; Kostinov MP; Petrov DV; Sel'kova EP; Putilovskiĭ MA; Nechaev VB; Epshteĭn OI; Andrianova EN
Antibiot Khimioter; 2012; 57(7-8):23-30. PubMed ID: 23350191
[TBL] [Abstract][Full Text] [Related]
8. Phase 2b Study of Pimodivir (JNJ-63623872) as Monotherapy or in Combination With Oseltamivir for Treatment of Acute Uncomplicated Seasonal Influenza A: TOPAZ Trial.
Finberg RW; Lanno R; Anderson D; Fleischhackl R; van Duijnhoven W; Kauffman RS; Kosoglou T; Vingerhoets J; Leopold L
J Infect Dis; 2019 Mar; 219(7):1026-1034. PubMed ID: 30428049
[TBL] [Abstract][Full Text] [Related]
9. The combination of oseltamivir with azithromycin does not show additional benefits over oseltamivir monotherapy in mice infected with influenza A(H1N1)pdm2009 virus.
Fage C; Pizzorno A; Rhéaume C; Abed Y; Boivin G
J Med Virol; 2017 Dec; 89(12):2239-2243. PubMed ID: 28792077
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy and safety of oseltamivir in children with suspected influenza: a multicenter randomized open-label trial].
He CH; Liu CY; Lin GY; Peng Q; Liao JY; Lin JH; Zhang T; Zheng XF; Lin CX; Wang SJ; Chen RS; Deng L; Chen YM
Zhonghua Er Ke Za Zhi; 2017 Jun; 55(6):462-467. PubMed ID: 28592016
[No Abstract] [Full Text] [Related]
11. Early treatment with baloxavir marboxil in high-risk adolescent and adult outpatients with uncomplicated influenza (CAPSTONE-2): a randomised, placebo-controlled, phase 3 trial.
Ison MG; Portsmouth S; Yoshida Y; Shishido T; Mitchener M; Tsuchiya K; Uehara T; Hayden FG
Lancet Infect Dis; 2020 Oct; 20(10):1204-1214. PubMed ID: 32526195
[TBL] [Abstract][Full Text] [Related]
12. [A randomized controlled study of peramivir, oseltamivir and placebo in patients with mild influenza].
Fan HW; Han Y; Liu W; Li XW; Li LZ; Yao HY; Wang Y; Su ZQ; Ye WX; Huang J; Lu WZ; Li GW; Li HL; Wang SY; Wu H; Lu QF; Zhu GF; Liu SM; Chen G; Zhang WH; Li TS
Zhonghua Nei Ke Za Zhi; 2019 Aug; 58(8):560-565. PubMed ID: 31365976
[No Abstract] [Full Text] [Related]
13. Oseltamivir compared with the Chinese traditional therapy maxingshigan-yinqiaosan in the treatment of H1N1 influenza: a randomized trial.
Wang C; Cao B; Liu QQ; Zou ZQ; Liang ZA; Gu L; Dong JP; Liang LR; Li XW; Hu K; He XS; Sun YH; An Y; Yang T; Cao ZX; Guo YM; Wen XM; Wang YG; Liu YL; Jiang LD
Ann Intern Med; 2011 Aug; 155(4):217-25. PubMed ID: 21844547
[TBL] [Abstract][Full Text] [Related]
14. Clinical and virological outcomes with baloxavir compared with oseltamivir in pediatric patients aged 6 to < 12 years with influenza: an open-label, randomized, active-controlled trial protocol.
Ishiguro N; Morioka I; Nakano T; Furukawa M; Tanaka S; Kinoshita M; Manabe A
BMC Infect Dis; 2021 Aug; 21(1):777. PubMed ID: 34372769
[TBL] [Abstract][Full Text] [Related]
15. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China.
Cao B; Li XW; Mao Y; Wang J; Lu HZ; Chen YS; Liang ZA; Liang L; Zhang SJ; Zhang B; Gu L; Lu LH; Wang DY; Wang C;
N Engl J Med; 2009 Dec; 361(26):2507-17. PubMed ID: 20007555
[TBL] [Abstract][Full Text] [Related]
16. Phase III randomized, double-blind study comparing single-dose intravenous peramivir with oral oseltamivir in patients with seasonal influenza virus infection.
Kohno S; Yen MY; Cheong HJ; Hirotsu N; Ishida T; Kadota J; Mizuguchi M; Kida H; Shimada J;
Antimicrob Agents Chemother; 2011 Nov; 55(11):5267-76. PubMed ID: 21825298
[TBL] [Abstract][Full Text] [Related]
17. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of a new bioequivalent formulation of oseltamivir (Enfluvir®) on 2010-2011 seasonal influenza viruses: an open phase IV study.
Ceyhan M; Karadag Oncel E; Badur S; Ciblak MA; Alhan E; Celik US; Kurugol Z; Saz EU; Ozsurekci Y; Celik M; Parlakay AO
Int J Infect Dis; 2012 Apr; 16(4):e273-8. PubMed ID: 22310296
[TBL] [Abstract][Full Text] [Related]
19. Triple-combination antiviral drug for pandemic H1N1 influenza virus infection in critically ill patients on mechanical ventilation.
Kim WY; Young Suh G; Huh JW; Kim SH; Kim MJ; Kim YS; Kim HR; Ryu YJ; Han MS; Ko YG; Chon GR; Lee KH; Choi SH; Hong SB;
Antimicrob Agents Chemother; 2011 Dec; 55(12):5703-9. PubMed ID: 21968371
[TBL] [Abstract][Full Text] [Related]
20. Efficacy comparison of oseltamivir alone and oseltamivir-antibiotic combination for early resolution of symptoms of severe influenza-A and influenza-B hospitalized patients.
Ishaqui AA; Khan AH; Sulaiman SA; Alsultan M; Khan I
Saudi Med J; 2020 Sep; 41(9):1015-1021. PubMed ID: 32893285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
